CVS Health (CVS) Ratios
CVS Health Ratios
MX:CVS's free cash flow for Q2 2026 was $5.65B. For the 2026 fiscal year, MX:CVS's free cash flow was decreased by $-691.00M and operating cash flow was $6.34B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 0.81 | 0.86 | 0.95 | 0.88 |
| Quick Ratio | 0.63 | 0.60 | 0.63 | 0.67 | 0.62 |
| Cash Ratio | 0.10 | 0.10 | 0.10 | 0.19 | 0.14 |
| Solvency Ratio | 0.03 | 0.05 | 0.07 | 0.05 | 0.08 |
| Operating Cash Flow Ratio | 0.12 | 0.11 | 0.17 | 0.23 | 0.27 |
| Short-Term Operating Cash Flow Coverage | 1.83 | 1.59 | 4.52 | 9.10 | 4.34 |
| Net Current Asset Value | $ -110.97B | $ -108.84B | $ -105.23B | $ -90.87B | $ -97.61B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.33 | 0.32 | 0.31 | 0.33 |
| Debt-to-Equity Ratio | 1.24 | 1.10 | 1.04 | 0.99 | 1.01 |
| Debt-to-Capital Ratio | 0.55 | 0.52 | 0.51 | 0.50 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.49 | 0.44 | 0.43 | 0.41 | 0.41 |
| Financial Leverage Ratio | 3.47 | 3.35 | 3.27 | 3.19 | 3.10 |
| Debt Service Coverage Ratio | 1.06 | 1.39 | 2.73 | 2.67 | 2.23 |
| Interest Coverage Ratio | 3.33 | 2.88 | 5.17 | 3.48 | 5.32 |
| Debt to Market Cap | 0.78 | 1.17 | 0.61 | 0.43 | 0.41 |
| Interest Debt Per Share | 76.33 | 68.21 | 63.85 | 55.65 | 59.52 |
| Net Debt to EBITDA | 8.63 | 5.43 | 3.91 | 4.68 | 3.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.77% | 13.79% | 15.21% | 16.90% | 17.84% |
| EBIT Margin | 1.31% | 2.44% | 3.87% | 2.52% | 4.46% |
| EBITDA Margin | 2.45% | 3.67% | 5.09% | 3.83% | 6.00% |
| Operating Profit Margin | 2.58% | 2.28% | 3.84% | 2.47% | 4.56% |
| Pretax Profit Margin | 0.53% | 1.65% | 3.12% | 1.81% | 3.61% |
| Net Profit Margin | 0.44% | 1.24% | 2.33% | 1.34% | 2.74% |
| Continuous Operations Profit Margin | 0.43% | 1.23% | 2.34% | 1.34% | 2.73% |
| Net Income Per EBT | 82.77% | 75.05% | 74.68% | 73.87% | 75.93% |
| EBT Per EBIT | 20.57% | 72.19% | 81.30% | 73.37% | 79.17% |
| Return on Assets (ROA) | 0.68% | 1.82% | 3.34% | 1.89% | 3.43% |
| Return on Equity (ROE) | 2.35% | 6.11% | 10.91% | 6.03% | 10.66% |
| Return on Capital Employed (ROCE) | 6.02% | 5.05% | 8.06% | 5.01% | 8.06% |
| Return on Invested Capital (ROIC) | 4.72% | 3.61% | 5.87% | 3.63% | 5.90% |
| Return on Tangible Assets | 1.18% | 3.43% | 6.46% | 3.44% | 6.41% |
| Earnings Yield | 1.76% | 8.16% | 8.22% | 3.53% | 5.88% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.11 | 10.22 | 10.16 | 11.82 | 11.96 |
| Payables Turnover | 5.84 | 20.22 | 20.36 | 18.06 | 19.13 |
| Inventory Turnover | 18.01 | 17.75 | 16.83 | 14.04 | 13.51 |
| Fixed Asset Turnover | 14.33 | 12.88 | 11.76 | 10.49 | 9.12 |
| Asset Turnover | 1.54 | 1.47 | 1.43 | 1.41 | 1.25 |
| Working Capital Turnover Ratio | -26.86 | -27.32 | -47.33 | -55.66 | -43.45 |
| Cash Conversion Cycle | -6.14 | 38.22 | 39.70 | 36.67 | 38.46 |
| Days of Sales Outstanding | 36.11 | 35.71 | 35.94 | 30.87 | 30.53 |
| Days of Inventory Outstanding | 20.26 | 20.56 | 21.69 | 26.00 | 27.01 |
| Days of Payables Outstanding | 62.52 | 18.05 | 17.92 | 20.21 | 19.08 |
| Operating Cycle | 56.37 | 56.27 | 57.63 | 56.88 | 57.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.40 | 7.23 | 10.45 | 12.33 | 13.85 |
| Free Cash Flow Per Share | 6.16 | 5.02 | 8.09 | 10.25 | 11.94 |
| Dividend Paid and CapEx Coverage Ratio | 1.71 | 1.48 | 2.18 | 2.87 | 3.55 |
| Capital Expenditure Coverage Ratio | 3.76 | 3.27 | 4.43 | 5.93 | 7.25 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.11 | 0.17 | 0.23 | 0.24 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.02 | 0.04 | 0.05 | 0.06 |
| Free Cash Flow Yield | 7.76% | 11.19% | 10.25% | 11.00% | 11.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 56.69 | 12.25 | 12.16 | 28.36 | 17.01 |
| Price-to-Sales (P/S) Ratio | 0.25 | 0.15 | 0.28 | 0.38 | 0.47 |
| Price-to-Book (P/B) Ratio | 1.34 | 0.75 | 1.33 | 1.71 | 1.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.88 | 8.93 | 9.76 | 9.09 | 8.64 |
| Price-to-Operating Cash Flow Ratio | 9.45 | 6.21 | 7.56 | 7.56 | 7.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.92 | -0.28 | 0.13 | -0.63 | 1.79 |
| Enterprise Value Multiple | 18.82 | 9.56 | 9.49 | 14.58 | 11.56 |
| Enterprise Value | 185.63B | 130.85B | 172.65B | 180.05B | 202.66B |
| EV to EBITDA | 18.82 | 9.56 | 9.49 | 14.58 | 11.56 |
| EV to Sales | 0.46 | 0.35 | 0.48 | 0.56 | 0.69 |
| EV to Free Cash Flow | 23.78 | 20.68 | 16.61 | 13.39 | 12.87 |
| EV to Operating Cash Flow | 17.45 | 14.37 | 12.86 | 11.13 | 11.10 |
| Tangible Book Value Per Share | -28.10 | -34.05 | -34.14 | -23.77 | -24.84 |
| Shareholders’ Equity Per Share | 59.36 | 60.02 | 59.50 | 54.47 | 56.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.25 | 0.25 | 0.26 | 0.24 |
| Revenue Per Share | 317.34 | 296.12 | 278.42 | 245.78 | 221.46 |
| Net Income Per Share | 1.40 | 3.66 | 6.49 | 3.29 | 6.07 |
| Tax Burden | 0.83 | 0.75 | 0.75 | 0.74 | 0.76 |
| Interest Burden | 0.41 | 0.68 | 0.81 | 0.72 | 0.81 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.16 | 1.99 | 1.60 | 3.74 | 2.29 |
Currency in USD
